Skip to main navigation Skip to search Skip to main content

Recurrence and Survival after Total Mesorectal Excision for Rectal Cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter discusses the long-term outcomes of the first reported series of rectal cancers managed with total mesorectal excision (TME) by a single surgeon (Dr. R. J. Heald). A total of 115 patients were included with 60% having an anastomosis below 5 cm. After a median follow-up of 4.2 years, the 5-year cumulative risk of local recurrence was 3.7%, and the 5-year overall survival was 87%. These results are of particular significance when contextualized in an era where local failure rates were as high as 30%, and no perioperative chemotherapy and/or radiation were administered. This landmark study popularized the implementation of standardized curative TME as the standard for rectal surgery.

Original languageEnglish (US)
Title of host publication50 Landmark Papers Every Colorectal Surgeon Should Know
PublisherCRC Press
Pages90-93
Number of pages4
ISBN (Electronic)9781040019313
ISBN (Print)9780367250423
DOIs
StatePublished - Jan 1 2024

Bibliographical note

Publisher Copyright:
© 2024 selection and editorial matter, John Monson, Lawrence Lee and Fergal Fleming.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Recurrence and Survival after Total Mesorectal Excision for Rectal Cancer'. Together they form a unique fingerprint.

Cite this